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Abstract
In human cell, a subset of small non-coding RNAs is imported into mitochondria from the cytosol. Analysis of the tRNA
import pathway allowing targeting of the yeast tRNALysCUU into human mitochondria demonstrates a similarity between the
RNA import mechanisms in yeast and human cells. We show that the cytosolic precursor of human mitochondrial lysyl-tRNA
synthetase (preKARS2) interacts with the yeast tRNALysCUU and small artificial RNAs which contain the structural elements
determining the tRNA mitochondrial import, and facilitates their internalization by isolated human mitochondria. The tRNA
import efficiency increased upon addition of the glycolytic enzyme enolase, previously found to be an actor of the yeast
RNA import machinery. Finally, the role of preKARS2 in the RNA mitochondrial import has been directly demonstrated
in vivo, in cultured human cells transfected with the yeast tRNA and artificial importable RNA molecules, in combination
with preKARS2 overexpression or downregulation by RNA interference. These findings suggest that the requirement of
protein factors for the RNA mitochondrial targeting might be a conserved feature of the RNA import pathway in different
organisms.
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Introduction
Mitochondria are essential organelles of almost all eukaryotic
cells and take part in several critical cellular processes. They
contain their own genome and perform transcription and
translation of their genetic material. However, the vast majority
of biological macromolecules found in mitochondria are imported
from the cytosol. For instance, the total number of mitochondrial
protein species is about 850–900 whereas the mitochondrial
genome codes for only 8 proteins in yeast and 13 ones in human
cells, so all other proteins are imported from the cytosol. The
mechanisms of protein import into mitochondria are described in
detail and appear as universal for all eukaryotes [1,2]. The
situation is different for RNA: several types of small non-coding
RNAs were suggested to be imported into mitochondria in
different species, and the mechanisms of these processes are
believed to be different in each case (see for review [3,4,5]).
In yeast Saccharomyces cerevisiae, the cytosolic tRNALysCUU
(further referred to as tRK1) is transcribed from a nuclear gene
and then unequally redistributed between the cytosol (97–98%)
and mitochondria (2–3%) [6]. The mitochondrial pathway was
shown to be essential for mitochondrial translation at elevated
temperatures, when the mtDNA-encoded isoacceptor tRNALy-
s
UUU becomes undermodified at the wobble position of the
anticodon and loses its capacity to recognize the lysine AAG codon
[7]. The mitochondrial targeting of tRK1 in yeast in vitro and
in vivo was shown to depend on the cytosolic precursor of
mitochondrial lysyl-tRNA synthetase (preMSK1p), which serves
as a carrier [8,9], and the glycolytic enzyme enolase (Eno2p)
[10,11]. Analysis of conformational rearrangements in the RNA
by in-gel FRET approach permitted to demonstrate that binding to
the protein factors and the subsequent RNA import require
formation of an alternative structure, different from the classic L-
form tRNA model. In the complex with Eno2p, tRK1 adopts a
particular conformation characterized by bringing together the 39-
end and the TYC loop and forming a structure referred to as F-
hairpin (Fig. 1A) [12]. We suggested that only those RNAs that are
able to form a stable alternative F-stem proceed to the
mitochondrial import pathway involving specific interactions with
the carrier protein, preMSK1p, and membrane receptors [13].
Exploiting these data, a set of small RNA molecules based on
the F-hairpin sequence, with a significantly improved efficiency of
import not only into yeast but also into human mitochondria
in vitro and in vivo, have been constructed. This opened a possibility
to design a new vector system capable to target therapeutic
oligoribonucleotides into deficient human mitochondria [12]. So
far, the RNA import is the only known natural mechanism of
nucleic acid delivery into human mitochondria. Since many
incurable neuromuscular diseases have been associated with
mtDNA mutations, the RNA import represents a promising tool
for the future gene therapy. The allotopic (nuclear) expression of
recombinant tRNA molecules importable into mitochondria has
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been exploited to partially correct the pathogenic effect of mtDNA
mutations in human cells [14,15,16]. Recently, we demonstrated
that replication of mtDNA containing a pathogenic mutation can
be specifically affected by RNA molecules bearing oligonucleotide
stretches complementary to the mutated region. These molecules
can be targeted into human mitochondria in vivo using artificially
engineered RNA vectors based on the tRK1 alternative structure
(Fig. 1A, B) [17]. To further develop and optimize this approach,
we need to understand the molecular mechanism of RNA
targeting into human mitochondria, especially the protein factors
participating in this process. This question is addressed in the
present study.
It was previously found that the synthetic transcripts of yeast
tRNAsLys and a number of their mutant versions could be
specifically internalized by isolated human mitochondria in the
presence of yeast or human soluble cytosolic proteins, indicating
Figure 1. Predicted structures of the yeast tRNALysCUU (tRK1) and small synthetic RNAs. (A) Two alternative structures of tRK1, as in [12].
The cloverleaf structure is shown at the left, the F-structure at the right. The tRK1 amino acceptor stem is in red, the D-arm in blue and the T-arm in
purple. (B) Secondary structures of small synthetic ‘‘anti-replicative’’ RNAs composed of the tRK1 D-arm (in blue) and the F helix-loop structure (in
red), separated by oligonucleotide stretches complementary to the heavy or light strands of human mitochondrial DNA [17]. (C) Truncated RNA
molecules derived from FD-L RNA lacking either the D-arm of tRK1 (HF RNA) or the F-hairpin (HD RNA). The nucleotides added to the 59-end of HF
RNA to improve T7-transcription are underlined. For HF RNA, only one secondary structure (dG=211.6 kcal/mol) was predicted byMfold, for HD RNA,
a structure with the minimal initial dG=25.9 kcal/mol is shown.
doi:10.1371/journal.pone.0066228.g001
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that the human cell possesses the machinery needed for the tRNA
mitochondrial import [18,19]. We also suggested that the cytosolic
precursor of human mitochondrial lysyl-tRNA synthetase (pre-
KARS2) could replace its yeast homologue preMSK1p and serve
as a carrier for tRK1 [19]. In human cells, a single KARS1 gene
codes for both mitochondrial and cytosolic lysyl-tRNA-synthetases
which are translated from two mRNAs generated by alternative
splicing [20]. Here we use abbreviations KARS2 and preKARS2
for the mature mitochondrial enzyme and its cytoplasmic
precursor, correspondingly, and KARS1 for the cytosolic enzyme.
Recently, another research group has demonstrated that the
recombinant KARS2 can substitute preMSK1p in targeting tRK1
into isolated yeast and mammalian mitochondria in the presence
of the yeast cytosol [21].
Here we show that preKARS2 has an affinity to tRK1 and
artificial RNA molecules containing the structural elements which
determine the tRK1 mitochondrial import. These molecules can
be targeted into isolated human mitochondria in the presence of
preKARS2 and mammalian enolase, thus demonstrating a
similarity to the yeast system. Finally, the role of preKARS2 in
the RNA mitochondrial import is, for the first time, demonstrated
in vivo, in human cells transfected with tRK1 and artificial
importable RNA molecules.
Results
PreKARS2 Binds tRK1 and Artificial Importable RNA
Molecules
To study the implication of the cytosolic precursor of human
mitochondrial lysyl-tRNA synthetase (preKARS2) in the mito-
chondrial import of the yeast cytosolic tRNALysCUU (tRK1), we
first analysed the interaction of the recombinant preKARS2 with a
T7-transcript of tRK1 by EMSA (Fig. 2), using labeled RNA and
increasing concentrations of the protein, as described [10]. The
apparent Kd of the complex was estimated as 300+/250 nM.
Thus, the affinity of preKARS2 to tRK1 is only slightly lower than
that of its yeast homolog, preMSK1p, with the apparent Kd
previously evaluated as 280+/260 nM [9]. Noteworthily, the
recombinant protein lacking the mitochondrial targeting pre-
sequence predicted by Mitoprot [20] and thus corresponding to
the mature mitochondrial enzyme KARS2 was not able to interact
with tRK1 (Fig. 2A). This finding parallels our previous study
suggesting a particular way of interaction between tRK1 and yeast
preMSK1p which does not lead to the tRNA aminoacylation [8].
Previous analysis of RNA aptamers imported into human
mitochondria permitted us to design short synthetic RNAs
comprising two domains of the tRK1 alternative structure
(Fig. 1 A, B) and characterized by a high efficiency of
mitochondrial targeting [12,17]. The molecules referred to as
FD-L and FD-H, containing the D-arm and F-hairpin parts of
tRK1 separated by 17–22 nucleotides stretches, were able to form
complexes with the recombinant preKARS2 with the apparent Kd
of 400+/250 nM, indicating a lower but still important affinity to
preKARS2 (Fig. 2B). The specificity of the interaction was
verified by North-Western hybridization in the presence of specific
and nonspecific competitors (Fig. 2D). The data show that 306
molar excess of cold E. coli rRNA only partially decreased the
interaction of preKARS2 with labeled tRK1 and FD-L RNA,
whereas the 106 molar excess of cold FD-R RNA completely
abolished this interaction.
To study more precisely the role of each of the two stem-loop
RNA domains, we constructed truncated FD-L RNA molecules
(Fig. 1C) lacking either the D-arm (HF RNA) or the F-hairpin
(HD RNA) of tRK1. Neither molecule was able to interact with
preKARS2 (Fig. 2C), indicating the importance of the simulta-
neous presence of the D-arm and the F-hairpin for the RNA
affinity to preKARS2.
PreKARS2 can Direct the RNA Import into Isolated
Human Mitochondria
Previously, we suggested that preKARS2 might replace
preMsk1p in the import of tRK1 into human mitochondria
[19]. To demonstrate this directly, the in vitro import test was
performed by incubating the proteins and the labelled RNA with
purified mitochondria from HepG2 cells, as described [22]. We
tested the recombinant preKARS2 in combination with rabbit
enolase, since our previous study of the tRK1 import into yeast
mitochondria had shown that yeast enolase recognizes the
imported tRNA and favours its binding to preMSK1p [10].
Purified human mitochondria were not able to internalize the
external tRK1 in the absence of protein factors (Fig. 3). Control
reactions without mitochondria or in the absence of ATP (Fig. 3A)
demonstrate that the proteins do not protect the RNA from
nuclease digestion. Upon addition of mitochondria and the
recombinant preKARS2, a portion of tRK1 and the small
artificial RNAs FD-L and FD-H has been protected from nuclease
degradation (Fig. 3 A, B), thus indicating their import into the
mitochondria. The amount of the imported RNA was determined
by comparison of the band density of the protected full-size RNA
isolated from the mitoplasts after the import assay with that of an
aliquot of the input labelled RNA, as shown in Fig. 3. As it was
demonstrated previously [18,19], only a minor fraction (1–5%) of
the tRK1 added to the import mixture is transported into the
isolated human organelles, corresponding to the in vivo situation in
yeast [6] [23].
The amount of the imported RNA increased upon addition of
rabbit enolase to the import mixture in combination with
preKARS2, however, the effect of enolase was dependent on the
RNA structure. tRK1 was very poorly imported with preKARS2
alone but its import has been significantly improved upon addition
of either rabbit or yeast enolase (Fig. 3A), demonstrating the
interchangeability of the yeast and mammalian targeting systems.
The recombinant human enolase (hEno1) had the same effect on
the tRK1 import in vitro as the rabbit one (not shown).
In contrast to the situation with tRK1, the level of mitochon-
drial import of the FD-L and FD-H RNA molecules was rather
high in the presence of preKARS2 alone and has only been
slightly improved upon rabbit enolase addition (Fig. 3B). These
data are in agreement with our model suggesting that only in the
alternative F-conformation tRK1 acquires a high enough affinity
to preMsk1p (Fig. 1A), and the RNA-chaperone activity of
enolase is necessary for this structural rearrangement [12].
According to this suggestion, the presence of enolase should not
be so important for the FD-L and FD-H RNA molecules, since
they do not need the structural rearrangements for the interaction
with preKARS2 and mitochondrial targeting.
As expected, the truncated RNA molecules HF and HD, which
cannot interact with preKARS2, have not been directed into
human mitochondria by this protein, independently of the
presence of rabbit enolase (Fig. 3C).
Implication of preKARS2 in the RNA Mitochondrial Import
in vivo
To compare the in vitro and in vivo import requirements, the role
of preKARS2 in the mitochondrial RNA targeting was studied in
cultured human cells. For this, we used the in vivo import assay on
the cells transfected with RNA molecules, as described [12,24]. To
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downregulate preKARS2, cultured human HepG2 cells were
transiently transfected with a mixture of two siRNAs specifically
designed against the part of the preKARS2 mRNA corresponding
to the mitochondrial targeting sequence. Three days after the
second transfection (see Methods section for details), a drop of
more than 70% was observed for preKARS2 by Western blot
(Fig. 4A). To evaluate the effect of the preKARS2 downregulation
on the RNA import into mitochondria, the cells were transfected
with purified T7-transcripts of tRK1, FD-L or FD-H. The whole
cell RNA and mitochondrial RNA were isolated from the control
and preKARS2-downregulated cells and analysed by Northern
blot hybridization (Fig. 4B). The absence of signal in the
mitochondrial RNA after hybridization with the probe against
the cytoplasmic 5.8S rRNA indicates that the treatment of
mitochondria with ribonuclease and digitonin removed all
contamination by cytoplasmic RNA. The amount of tRK1
molecules internalized by the cells was quantified by Northern
blot hybridization using known amounts of T7-transcripts loaded
on the same gel as standards. By this approach, we could estimate
that 10.860.5% of the tRK1 added to the cells were internalized
and could be detected in the full-size form 48 h after transfection.
This value corresponds to 2.660.26106 RNA molecules per cell,
which number is in the range of most abundant cellular RNAs, for
example, 5S rRNA, estimated previously as 3.660.56106 RNA
molecules per cell [19]. The number of tRK1 molecules in the
mitochondrial fraction corresponded to 4.660.46104 RNA
molecules per cell, giving 2.560.3% of the molecules imported
into mitochondria from the cellular pool, which perfectly
correlates with our in vitro data.
We observed a clear difference in the mitochondrial RNA
import between the control and preKARS2-downregulated cells:
the tRK1 import decreased 2-fold, and a 2.5-3-fold reduction was
observed for the small artificial FD-L and FD-H RNAs import
(Fig. 4B).
To confirm the role of preKARS2 as a mitochondrial targeting
factor for tRK1 and its derivatives, we tested the RNA
mitochondrial import in cells overexpressing preKARS2. For this,
we used HeLa Tet-Off cells transiently transfected with a plasmid
expressing preKARS2 (generous gift of M. Mirande, Gif-sur-
Yvette, France). In 48 h after transfection, a 2- to 3-fold increase of
the preKARS2 protein amount in the cell extract was detected
(Fig. 4C), in agreement with previously published data [25]. The
cells overexpressing the preKARS2 protein were transfected with
tRK1, FD-L or FD-H, and the mitochondrial RNA import was
analysed by Northern blot hybridization (Fig. 4D), compared to
control cells transfected with an empty vector. The mitochondrial
import of all three RNA molecules, tRK1, FD-L and FD-H,
increased 2-fold in the cells over-expressing preKARS2, confirm-
ing that the amount of the RNA molecules penetrating into
mitochondria in human cells depends on the level of the
preKARS2 protein expression.
All the data presented above clearly indicate the role of the
human mitochondrial lysyl-tRNA synthetase preKARS2 in the
mitochondrial targeting of yeast tRK1 and the artificial RNA
Figure 2. Interaction of the purified KARS2 and preKARS2 proteins with RNAs tested by EMSA. After incubation of 32P-labeled tRK1 (A),
FD-L and FD-H RNAs (B) or the truncated HD and HF RNAs (C) with increasing concentrations of the recombinant proteins (indicated above the
panels, in nM), the complex formation was visualized by autoradiography. In each assay, the bottom band corresponds to the free RNA species, the
RNA-protein complex is marked with an arrowhead. The deduced dissociation constants (Kd) for each RNA are given at the bottom of the panel (in
nM). A representative of at least three independent experiments is shown for each RNA. (D) North-Western hybridization. Membrane stripes,
containing equal amounts of preKARS2, were incubated with labeled RNAs (indicated above). Lane 1, no competitor added; lane 2, hybridization in
the presence of 306molar excess of nonspecific competitor (rRNA E. coli); lane 3, hybridization in the presence of 106molar excess of nonlabeled
RNA FD-R. Left panel represents the membrane stained with Ponceau Red.
doi:10.1371/journal.pone.0066228.g002
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Figure 3. Import of RNA into isolated HepG2 mitochondria. Autoradiographies of RNA isolated from purified mitochondria and separated in
denaturing 10% PAAG are presented. (A) Import of yeast tRK1, +*, yeast enolase was added instead of rabbit one. (B) Import of the small synthetic
RNAs FD-L and FD-H. (C) Import of the truncated HD and HF RNAs. The name and position of the full-size RNA is indicated by an arrow on the left of
each panel. Input, 2–5% of the RNA used for each assay (as indicated above the lane), corresponding to 60–150 fmoles of labeled RNA. Mitochondria
tRNA Import into Human Mitochondria
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molecules containing two structural elements of the tRK1
alternative ‘‘import-active’’ fold, the D-arm and the F-hairpin.
Mitochondrial Import of Truncated RNA Molecules is not
Dependent on preKARS2
Surprisingly, the small artificial RNA molecules containing
either the D-arm or the F-hairpin (referred to as HD and HF,
Fig. 1C), which were not imported into isolated human
mitochondria in vitro, were internalized by mitochondria in vivo
(Fig. 5A, B). A possible explanation of this discrepancy could be
that our in vitro import conditions may not allow for a correct
(predicted) folding of the short truncated RNA molecules.
Nevertheless, the same RNAs internalized by cells, were able to
be folded and imported into mitochondria.
To verify the specificity of our import test, we designed an
artificial control RNA of a size similar to that of the HF and HD
molecules (43 nt) but unrelated to yeast tRK1 and containing a
short G-C stem and a long unstructured loop (Fig. 5C). This
control RNA was not able to interact with the recombinant
preKARS2 and to be imported into isolated human mitochondria
in the presence of the purified proteins, preKARS2 and rabbit
enolase (Fig. 5C, middle panel). Contrary to HD and HF RNAs,
the control RNA was not detected in mitochondria of transfected
HepG2 cells (Fig. 5C, right panel), indicating that not any short
RNA molecule can be imported but only those containing the
structural import determinants.
As it has been shown above, the HD and HF RNA molecules
lack the capacity to interact with the recombinant preKARS2 and
to be imported into isolated human mitochondria in the presence
of preKARS2 and rabbit enolase (Fig. 3C). In agreement with
these data, the in vivo import of these RNAs was not dependent on
preKARS2, since no change in the amount of the RNA molecules
transported into mitochondria was observed when preKARS2 had
been transiently downregulated or overexpressed (Fig. 5A, B).
This suggests implication of other protein factor(s) in the import of
these RNAs into mitochondria in vivo.
To check if the mitochondrial targeting of the truncated RNAs
is still dependent on protein factors, we isolated crude proteins
from HepG2 cells, fractionated them by gel-filtration and tested
the main peaks, each representing a mixture of many proteins, for
their ability to direct RNA into isolated human mitochondria
(Fig. 5D). We detected an efficient import of both truncated
RNAs in the presence of one protein fraction (Fig. 5E), thus
demonstrating that the in vitro mitochondrial import of the HD
and HF RNA molecules is dependent on protein factors.
All presented data show that the RNA targeting into human
mitochondria is a flexible process, allowing to import not only a
full-size yeast tRNA but also its truncated versions. Import of
tRK1 and the RNAs containing both tRK1 import determinants
depends on the preKARS2 protein. Shorter truncated molecules
were shown to be imported with a help of other, so far unidentified
protein factor(s).
Discussion
PreKARS2 as a tRK1 Carrier to Human Mitochondria
In human cells, a subset of small non-coding RNA is imported
into mitochondria from the cytosol [26], including some tRNAs
(either in a natural or an artificial manner) [14,27], the RNA
components of RNase P and MRP endonuclease [28,29], and 5S
rRNA [30,31]. Analysis of the cryptic tRNA import pathway,
allowing the targeting of the yeast tRNALysCUU into human
mitochondria, performed in the present study demonstrated a
similarity between the tRK1 import mechanisms in yeast and
human cells. In yeast cells, preMSK1p and Eno2p were identified
as the tRK1 mitochondrial targeting factors [10,32]. A similar
tRNA import pathway in human cells involves the orthologous
proteins, preKARS2 and enolase. Moreover, the alternative
folding of tRK1 as a determinant for the mitochondrial targeting
in yeast [12] seems to be relevant in human cells as well, since we
show that artificial RNA molecules containing two hairpin
structures characteristic for the tRK1 alternative F-fold (Fig. 1A)
can be efficiently imported into human mitochondria in vitro and
in vivo, in a manner clearly dependent on the preKARS2 protein
(Fig. 3, 4).
Aminoacyl-tRNA-synthetases is a group of enzymes responsible
for the specific attachment of amino acids to their cognate tRNAs,
thus performing a key step of translation (reviewed in [33]). In
human cells, one gene KARS1 codes for both mitochondrial and
cytosolic lysyl-tRNA-synthetases which are produced from two
mRNAs generated by alternative splicing [20]. PreKARS2
possesses a specific N-terminal sequence of 49 amino acid residues,
which is the only difference from KARS1 [20,34]. The situation is
opposite in yeast S. cerevisiae where the mitochondrial and cytosolic
lysyl-tRNA-synthetases are encoded by distinct genes, MSK1 and
KRS1 [35]. PreMSK1p plays an essential role in the mitochondrial
targeting of the cytosolic tRNALysCUU (tRK1) in yeast [8].
Previously, it has been demonstrated that human preKARS2
overexpressed in yeast can partially complement the growth defect
associated with the loss of MSK1 and can additionally facilitate the
import of tRK1 into isolated yeast mitochondria [21]. Here we
demonstrate the direct interaction of preKARS2 (but not of its
mature form) with yeast tRK1 and the involvement of this protein
in the tRK1 import into human mitochondria in vivo.
Recently and rather surprisingly, the mature mitochondrial
enzyme KARS2 was shown to interact with the human cytosolic
tRNALys3 with an apparent Kd of 250+/240 nM, but the presence
of the mitochondrial targeting sequence in preKARS2 completely
abolished the RNA-binding properties of the protein (Kd .1 mM
for preKARS2) [34]. Since in human cells no import of tRNALys
into mitochondria had been observed [26], the apparent
discrepancy between these and our data clearly indicates a
different mode of preKARS2 interaction with either the non-
importable cytosolic tRNALys3 or the importable tRK1. This is in
agreement with our hypothesis that only the alternative fold of
tRNA can be recognized by the precursor of mitochondrial lysyl-
tRNA-synthetase functioning as an RNA mitochondrial carrier.
Thus, only yeast tRK1 and some specially designed RNA
molecules capable to adopt the alternative conformation can
interact with preKARS2 and be targeted into human mitochon-
dria.
RNA Targeting into Mitochondria: a Species-specific or a
Universal Mechanism?
In general, each known case of RNA mitochondrial import
appears somewhat special and thus not sufficient to establish a
common RNA import mechanism [36]. The results of the present
work, together with our previous data, enable us to revisit the
(+) corresponds to the complete import assay, Mitochondria (-) to the mock import assay without mitochondria used as a control for non-specific
protein-RNA aggregation. The RNA import efficiency was calculated by comparing the signal with the input and is indicated below each lane. A
representative of three independent experiments is presented for each RNA, 6SD indicated.
doi:10.1371/journal.pone.0066228.g003
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Figure 4. Implication of preKARS2 in the RNA mitochondrial import in vivo. (A) Western blot analysis of preKARS2 downregulation by RNA
interference (Si). The level of preKARS2 in the cells transiently transfected with siRNAs against preKARS2 (Si) compared to the control cells transfected
with a control siRNA (Ctrl) is indicated below the panel. The antibodies used for immunodecoration are shown on the right. (B) Northern blot
hybridization of the total and purified mitochondrial (mtRNA) RNAs isolated from the control cells (Ctrl) and the cells transfected with siRNAs against
preKARS2 (Si), in 32 h after transfection with tRK1, FD-L or FD-H RNA, as indicated. The hybridization probes are shown on the right. The mt tRNAVal
probe was used as loading control, and the cytosolic 5.8S rRNA probe was used to confirm the absence of cytosolic RNA contamination in the
mitochondrial RNA preparations. The relative RNA import efficiencies, taken as 1 for the control cells, are shown below each panel (see Methods for
the import efficiency calculation). For each RNA, the results of at least three independent experiments are shown at the lower panel, 6SD indicated.
(C) Western blot analysis of preKARS2 overexpression (OE), the relative level of overexpression is indicated below the panel. Ctrl, control cells
transfected with an empty vector. (D) Analysis of the in vivo import of tRK1 and the small synthetic FD-L and FD-H RNAs into mitochondria of the
control cells (Ctrl) and the preKARS2-overexpressing (OE) cells in 48 h after transfection with the corresponding RNAs. All indications are as in B.
doi:10.1371/journal.pone.0066228.g004
tRNA Import into Human Mitochondria
PLOS ONE | www.plosone.org 7 June 2013 | Volume 8 | Issue 6 | e66228
Figure 5. Import of small truncated RNAs into mitochondria. (A) In vivo import of the truncated HF (left panel) and HD (middle panel) RNAs in
mitochondria of the control cells and the cells overexpressing preKARS2. (B) In vivo import of HF and HD RNAs in the control cells and the cells with
downregulation of preKARS2. Hybridization probes are indicated on the right of the panels. Overexpression and downregulation of preKARS2 were
confirmed by Western blot as in Fig. 4A, C. The relative import efficiencies are shown on the right panels, 6SD calculated from three independent
experiments. (C) Secondary structure (on the left) of the artificial control RNA, predicted by Mfold. The control RNA in vitro (middle panel, indications
are as in Fig. 3) and in vivo (right panel) import tests. (D) OD280 absorption profile of HepG2 proteins separated by gel filtration on a Sephacryl G-200
column. (E) Import of HF RNA (upper panel) and HD RNA (lower panel) into isolated HepG2 mitochondria in the presence of proteins from the gel
filtration fractions indicated above the lanes. Input, 2–5% of RNA used for each assay. The RNA import efficiencies calculated by comparing with the
inputs, in fmoles of imported RNA per 0.1 mg of mitochondrial protein, are given below each lane. On each panel, a representative of at least three
independent experiments is shown, 6SD indicated.
doi:10.1371/journal.pone.0066228.g005
tRNA Import into Human Mitochondria
PLOS ONE | www.plosone.org 8 June 2013 | Volume 8 | Issue 6 | e66228
paradigm of ‘extremely diversified’ RNA import pathways and to
propose several rules which can be, if not universal, at least largely
applicable to various RNA import systems.
Firstly, to be imported into mitochondria, an RNA should
escape from the cytosolic channelling. According to this model, no
free diffusion of macromolecules inside the cell is normally possible
since all its components are well arranged in space and their
movements are strictly regularized (channelled). Channelling was
studied in detail on the example of tRNAs [37]. It was found that,
starting from the very transcription event, a tRNA molecule is
trapped in a standard sequence of events (processing, modification,
nuclear export, translation) assured by protein components that
function in a chain. They hand the tRNA from one to another
avoiding its release into solution (reviewed in [38]). To make an
RNA exit from the standard circuit, a well regulated deviation has
to be provided by a special mitochondrial targeting factor which
has a specific affinity to the cargo RNA. For example, in yeast
cells, tRK1 is probably captured from the translation cycle by the
glycolytic enzyme enolase and redirected to the mitochondrial
surface [10]. The same event apparently exists in the artificial
tRK1 import pathway in human cells, as we show here. In the case
of the 5S rRNA import, this function is performed by the cytosolic
precursor of mitochondrial ribosomal protein L18 (preMRP-L18)
[31]. To assure the irreversible RNA withdrawing from the
cytosolic channelling, the protein factor should possess a chaper-
one activity to change the RNA conformation, as it has been
shown for tRK1 in the complex with yeast enolase [12] or for 5S
rRNA and preMRP-L18 [31].
The next step of the pathway is a rapid discharge of the
chaperone by another mitochondrial import factor. Examples of
such a cascade were described in the yeast import mechanism
where tRK1 is quickly transferred from enolase to the precursor of
lysyl-tRNA synthetase [10]. A very similar case was observed for
5S rRNA in human cells where the mitochondrial enzyme
rhodanese accepts 5S rRNA from preMRP-L18 [30]. For both
mechanisms, a significant decrease in the apparent dissociation
constant for the complex between the second protein factor and
the RNA was found. Then, the second import factor works as a
carrier transporting the RNA molecule into the mitochondria. The
mechanism of RNA translocation across the double mitochondrial
membranes is not yet understood. Most probably, it exploits the
standard mitochondrial pre-protein localisation apparatus, since
carriers usually have signals of mitochondrial localisation and it
appears the most obvious way to reach the organelles. Neverthe-
less, one can not exclude alternative translocation mechanisms via
different membrane channels [4,29,39].
Thus, for all RNA import systems in which the pre-mitochon-
drial (targeting) step of RNA import has been investigated, several
universally present features can be outlined. Namely, in order to
direct a cytosolic RNA to mitochondria one needs necessarily two
protein factors, the first with a chaperone activity to withdraw the
RNA from the cytosolic channeling, the second possessing the
signal of mitochondrial localisation to target the RNA into the
mitochondria. One of these proteins should be cognate, interacting
with the imported RNA in a specific way and thus determining the
selectivity of the RNA import (preLysRS for tRK1, preMRP-L18
for 5S rRNA). The other protein factor may be unrelated to RNA
metabolism and hardly expected to participate in RNA transport,
performing thereafter a ‘‘second job’’, as enolase and rhodanese.
Concerning enolase, many non-glycolytic ‘‘moonlighting’’ func-
tions of this protein are known (reviewed in [40]). In E. coli, enolase
is an integral component of the RNA degradosome; in yeast, it was
identified as Hsp48 and participates in formation of vacuoles;
enolase is found in the eye lens of many organisms and as a
plasminogen-binding receptor expressed on the surface of a variety
of eukaryotic cells. Thus, the tRNA import into mitochondria
seems to be one of many different functions of this enzyme. The
mitochondrial enzyme rhodanese is less studied, in fact, even its
function is still not clear. We can hypothesize that this protein may
also have multiple functions which can be switched by its cellular
re-localization.
The common rules described here can be applied in search for
RNA import pathways in various eukaryots. For instance, it
appears that in plant cells, precursors of dually targeted cognate
aminoacyl-tRNA synthetases combine both RNA targeting
functions and thus may be the only essential tRNA import factors
[36]. Probably, the same situation may be found in Trypanosoma
brucei, where the cytosolic elongation factor eEF1a assures the
specific targeting of almost all tRNAs to mitochondria [41].
Mitochondrial Import of Small RNA Molecules
The general rules of RNA import formulated above presume
certain flexibility of the pathway. Indeed, various RNA molecules
able to interact with import factors can be targeted into
mitochondria even in organisms naturally importing only a very
restricted number of RNA species, as we see here for the RNAs
FD-H and FD-L. On the other hand, various proteins might
perform the function of RNA import factors in certain conditions.
This possibility is clearly demonstrated in the present work since
the short truncated RNA molecules HD and HF, which have lost
the capacity to interact with preKARS2, apparently can be
targeted into human mitochondria with the help of other, still
unidentified protein(s). This hypothesis is also in agreement with a
recent publication claiming that preMSK1p may be dispensable
for the tRK1 import into yeast mitochondria [21]. One can
suggest that in the yeast strain used in this study, lacking the MSK1
gene and thus devoid of actively respiring mitochondria, the small
amount of tRK1 detected in the pro-mitochondria could be
imported by a backup pathway with a help of alternative targeting
protein(s).
Recently, a subset of microRNAs, small non-coding RNAs that
associate with Argonaute proteins to regulate gene expression at
the post-transcriptional level, has been localized to human
mitochondria [42,43,44], as well as the AGO2 protein [45]. At
least a part of these miRNAs and their precursors were supposed
to be imported from the cytoplasm by an unknown mechanism. It
would be tempting to hypothesize that small structured RNA
molecules, such as HD and HF, might be recognized by the
machinery of the miRNA import and targeted to mitochondria by
AGO2 and/or another components of the RNA-inducible
silencing complex (RISC), which could thus perform the ‘‘second
job’’ as mitochondrial targeting factors, similarly to the enzymes
enolase or rhodanese. This exiting possibility remains to be
explored in future studies.
Materials and Methods
Plasmids and Antibodies
Plasmid pDEST17 expressing human mitochondrial lysyl-tRNA
synthetase (KARS2) was kindly provided by M. Sissler (IBMC,
Strasbourg). To produce the precursor of mitochondrial KARS2
(preKARS2) protein, the Quick change mutagenesis kit (Strata-
gene) was used to insert the mitochondrial targeting sequence at
the N-terminus of the mitochondrial KARS2 protein. A thrombin
cleavage site and a 66histidine tag at the N-terminus were deleted
and a 66 histidine tag was inserted at the C-terminus using the
same approach. For this, the following oligonucleotides were used:
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Mitochondrial Targeting Sequence Insertion
59GCCACGCGGTTCTTTGACGCAAGCTGCTG-
TAAGGCTTGTTAGGGGGTCCCTGCG-
CAAAACCTCCTGGGCAG 39
59CTGCCCAGGAGGTTTTGCGCAGGGACCCCCTAA-
CAAGCCTTACAGCAGCTTGCGTCAAA-
GAACCGCGTGGC 39
Thrombin Cleavage Site and 66His Tag Deletion
59 CTTTAAGAAGGAGATATACATATGTTGACG-
CAAGCTGCTGTAAGG39
59 CCTTACAGCAGCTTGCGTCAACATATGTA-
TATCTCCTTCTTAAAG 39
His Tag Insertion at the C-terminus of preKARS2
59 CAACAGTTGGCAGTTCTGTCCACCATCACCAT-
CACCATTGAGACCCAGCTTTCTTGTAC 39
59 GTACAAGAAAGCTGGGTCTCAATGGTGATGGT-
GATGGTGGACAGAACTGCCAACTGTTG 39
pTRE2hyg plasmid expressing preKARS2 and antibodies
directed against the residues 25 to 42 of the preKARS2 protein
described in [25] were kindly provided by Marc Mirande (Gif-sur-
Yvette, France). Polyclonal antibodies against human actin were
from Santa Cruz Biotechnology.
Purification of the Recombinant preKARS2 Protein
To obtain the recombinant KARS2 and preKARS2 proteins,
Escherichia coli strain BL21 codon plus (DE3)-RIL cells (Stratagene)
were transformed with the pDEST17 plasmid. The transformed
cells were grown in 500 ml of LB medium to a cell density
corresponding to OD600 = 0.6, then the protein expression was
induced for 2 h at 37uC by addition of 0.5 mM isopropyl b-D-1-
thiogalactopyranoside (IPTG) to the bacterial culture. The cells
were harvested by centrifugation at 6000 g for 10 min, lysed with
1 mg/ml of lysozyme on ice for 30 min and then sonicated thrice
for 20 sec in the buffer consisting of 50 mM NaH2PO4, 300 mM
NaCl and 20 mM imidazole. The cell lysate was centrifuged at
10,000 g for 15 min and the pellet was solubilized in the
denaturing buffer consisting of 100 mM Tris-HCl (pH 8),
100 mM NaH2PO4, 10 mM imidazole and 8 M urea. This was
followed by centrifugation at 12000 g for 15 min and the
supernatant was applied to a Ni-NTA column (Qiagen) for 2 h
at 4uC. After binding, the column was washed three times with the
denaturing buffer containing 20 mM imidazole to eliminate
weakly bound bacterial proteins. The recombinant preKARS2
protein was eluted from the column with 200 mM imidazole,
refolded by stepwise elimination of urea and finally dialyzed
against 50 mM Tris-HCl (pH 8), 300 mM NaCl and 40% glycerol
and stored at –20uC. The purity of the protein was checked by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) with Coomassie blue staining.
The recombinant yeast enolase Eno2p was isolated as described
previously [10]. Enolase from rabbit muscles was from Sigma-
Aldrich.
Recombinant RNA modeling. To predict secondary struc-
tures of recombinant RNA molecules and estimate their free
energies (dG), the Mfold program [46,47] and IDT Sci-Tools
OligoAnalyser 3.1 software [48] were used.
RNA synthesis and purification. The yeast tRK1 T7-
transcript was obtained as described [32]. For small artificial
RNAs, PCR amplification of the following oligonucleotides
containing a T7 promoter at the 59-end (underlined) was
performed:
FD-L TAATACGACTCACTATAGCGCAATCGG-
TAGCGCCTCTTTACAGTGCTTAGTTCTCGAGCCCCC-
TACAGGGCTCTT
FD-H TAATACGACTCACTATAGCGCAATCGG-
TAGCGCAGTAAGCACTGTAAATGAGCCCCCTA-
CAGGGCTCTT
HD: TAATACGACTCACTATAGCGCAATCGG-
TAGCGCCTCTTTACAGTGCTTAGTTCTC
HF: TAATACGACTCACTATAGGTCTTTACAGTGCT-
TACTTCTCGAGCCCCCTACAGGGCTCCA
RNA transcripts were obtained in vitro using the Ribomax kit
(Promega). Following transcription, the DNA template was
removed by digestion with RQ1 RNase-Free DNase (Promega).
RNAs were purified by 12% PAGE with 8 M urea and eluted
from the gel with the RNA extraction buffer containing 0.5 M
CH3COONH4, 10 mM Mg(CH3COO)2, 0.1 mM EDTA and
0.1% SDS. The eluted RNA was precipitated with ethanol.
Electrophoretic mobility shift assay (EMSA). Purified
RNA was dephosphorylated with alkaline phosphatase (Boehrin-
ger Mannheim) and labeled at the 59-end with c-32P-ATP using
T4 polynucleotide kinase (Promega). The labeled RNA was
denatured at 100uC and then slowly cooled down to the room
temperature. For RNA binding assays, the appropriate amount of
protein and labeled RNA were mixed in 20 ml of the buffer
containing 20 mM Tris–HCl pH 7.5, 150 mM NaCl, 10 mM
MgCl2, 5 mM DTT, 10% glycerol, 0.1 mg/ml BSA and
incubated at 30uC for 15 min. The mixture was separated by
native 8% PAGE in 0.56Tris-borate buffer (pH 8.3) and 5%
glycerol [49], followed by Typhoon-Trio (GE Healthcare)
scanning and quantification as described in [50].
North-Western blot hybridisation. Recombinant pre-
KARS2 was loaded on 10% SDS-PAAG and blotted to
nitocellulose membrane. The membrane was incubated in 0,1 M
Tris-HCl, 20 mM KCl, 2,5 mM MgCl2, 0,1% Nonidet P40,
pH7.5, at 4uC for 1 h with stirring, then washed several times with
the same solution and blocked in 10 mM Tris-HCl, pH7.5, 5 mM
Mg(CH3COO)2, 2 mM dithiothreitol, 2% BSA, 0,01% Triton X-
100 for 5 min at 25uC. Then, the membrane was incubated for
2 h at 4uC in the import buffer without sorbitol, containing 1 nM
[32P]-labelled RNA, as in [10], washed with the same buffer
without RNA and analysed by Typhoon-Trio (GE Healthcare)
scanning and quantification.
In vitro import assay. Mitochondria were isolated and
verified for intactness as described [22]. The standard in vitro
import assay into isolated mitochondria was performed as in [19].
For this, purified HepG2 mitochondria were incubated with
radioactively labeled RNA and purified proteins in the import
buffer: 0.6 M sorbitol, 20 mM HEPES-KOH (pH 7), 10 mM
KCl, 2.5 mM MgCl2, 5 mM DDT and 2 mM ATP. For a
standard in vitro assay, we add 3 pmoles of labelled RNA per
0.1 ml of the reaction mixture containing 0.1 mg of mitochondria
(measured by the amount of mitochondrial protein). This
corresponds to the 100% RNA input. After incubation for
15 min at 34uC, 50 mg/ml of RNase A (Sigma) was added and
the reaction was incubated for additional 15 min to digest all
unimported RNA. The mitochondria were washed three times
with the buffer containing 0.6 M sorbitol, 10 mM HEPES-KOH
(pH 6.7) and 4 mM EDTA, then resuspended in 100 ml of the
same buffer and treated with an equal volume of 0.2% digitonin
(Sigma) solution to disrupt the mitochondrial outer membrane,
followed by purification of mitoplasts. The mitoplast pellet was
resuspended in the solution containing 100 mM CH3COONa,
10 mMMgCl2, 1% SDS and 0.05% diethylpyrocarbonate
(DEPC), boiled for 1 min and RNA was extracted at 50uC
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with water-saturated phenol. RNA was precipitated with
ethanol and separated by 12% PAGE containing 8 M urea,
followed by quantification with the Typhoon-Trio scanner using
the Image Quant-Tools software (GE Healthcare). The amount of
the imported RNA was determined by comparison of the band
density of the protected full-sized RNA isolated from the
mitoplasts after the import assay with an aliquot (2–5%) of the
RNA input.
Human Cell Culture, Overexpression and Downregulation
of preKARS2
HeLa Tet-Off cells stably expressing the tetracycline-controlled
transactivator (tTA) were purchased from Clontech Laboratories
Inc. The HepG2 and HeLa Tet-Off cells were maintained in the
Dulbecco modified Eagle’s medium (DMEM, Invitrogen) with
high glucose (4.5 g/l) supplemented with 10% fetal calf serum,
100 mg/ml of streptomycin and 100 mg/ml of penicillin (Gibco).
For induction of protein expression in HeLa Tet-Off cells, the Tet
system approved fetal bovine serum from Clontech was used. The
cells were cultivated in a humidified atmosphere at 37uC and 5%
of CO2.
For overexpression of preKARS2, HeLa Tet-Off cells were
grown to the 60% confluency and transfected with the pTRE2hyg
plasmid expressing preKARS2 [25] using Lipofectamin 2000
(Sigma) according to the manufacturer’s protocol. At the same
time, the cells were transiently transfected with mitochondrially
importable RNAs. After 48 h, the cells were analysed for the
preKARS2 overexpression by Western blotting and for the RNA
import by Northern hybridization.
To downregulate preKARS2, two 21-mer siRNAs correspond-
ing to the mitochondrial targeting sequence of the human
preKARS2 mRNA were synthesized. The sequences of the sense
strands of these siRNAs are as follows: siRNA1:59
CAACTTGCTCCTTTCACAGCG 39 and siRNA2:59 AAGGA-
CAAGTCATTTTCTGAT 39. As a negative control, a non-
silencing siRNA (Ref: SR-CL000-005, Eurogentec) was used. Our
optimized protocol consisted of two subsequent transfections:
firstly, HepG2 cells were transfected in suspension with 40 nM of
each siRNA using the RNAiMax transfection reagent (Invitrogen),
according to the manufacturer’s protocol. 24 h later, the cells
formed a monolayer and were transfected again with 40 nM of
each siRNA using Lipofectamine 2000 (Invitrogen). The cells were
grown for 40 h after the second siRNA transfection and then
transfected with one of mitochondrially importable RNAs. In 3
days after the second siRNA transfection, the downregulation was
analysed by Western blotting, and the RNA import by Northern
hybridization.
RNA Import Assay in vivo
For transfection of HepG2 and HeLa Tet-Off cells, 3 mg of
RNA per 75 cm2 flask were used. Transfection was performed
with the Lipofectamine 2000 reagent (Invitrogen), according to the
manufacturer’s protocol. After 48 h, the cells were detached,
mitochondria were isolated and purified as described above. The
total and mitochondrial RNA were isolated with the TRIzol
reagent (Invitrogen), separated by 12% PAGE containing 8 M
urea and analysed by Northern blot hybridization with 59-32P-
labelled oligonucleotide probes:
anti-tRK1 (1–34): GAGTCATACGCGCTACC-
GATTGCGCCAACAAGGC to detect tRK1, FD-L, FD-H and
HD RNA;
anti-HF RNA probe: TGGAGCCCTGTAGGG;
anti-mt tRNAVal probe: GTTGAAATCTCCTAAGTG
and anti-cyt 5.8S rRNA probe: AAGTGACGCTCAGA-
CAGGCA.
After quantification with the Typhoon-Trio scanner, the
relative efficiency of the RNA import into mitochondria was
calculated as a ratio between the signal obtained with the anti-
tRK1 probe and that obtained with the probe against the host
mitochondrial tRNAVal, as described previously [24]. Because it is
rather difficult to normalize exactly the amount of mitoplasts
isolated from various cell lines, we load on the gel the
mitochondrial RNA isolated from the same number of cells, and
then use the hybridization signals corresponding to the mitochon-
drial tRNAVal as a loading control. Thus, we take into account not
the absolute intensity of hybridization signals but the ratios
between the signals corresponding to the imported into mito-
chondria tRK1 (or FD-RNAs) and the host mitochondrial valine
tRNA’s gene transcript. To calculate the absolute import
efficiencies for various RNAs, the total level of the RNAs in the
transfected cells was taken into account. For this the relative
import efficiencies were divided by the ratios calculated in the
same way but for the total RNA preparations.
Immunoblotting
For Western immunodecoration, cells were lysed in the
Laemmli buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 0.1% b-
mercaptoethanol, 0.01% bromophenol blue and 10% glycerol) for
10 min at 90uC, and 30 mg of protein was separated by 10% SDS-
PAGE. The proteins were electroblotted onto a nitrocellulose
membrane and probed with a primary polyclonal antibody against
preKARS2 and a commercially available polyclonal antibody
against actin (G2308, Santa Cruz Biotechnology). Bands were
visualized with anti-rabbit or anti-goat secondary antibodies
conjugated with horseradish peroxidase using the ECL Plus
Western Blotting detection reagent (GE Healthcare).
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